Publicacións nas que colabora con Antonio Cremades Mira (2)

2025

  1. NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC

    Cancer Letters, Vol. 633

2019

  1. CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC

    Cancer Research, Vol. 79, Núm. 17, pp. 4439-4452